Transient Anti-TCRβ mAb Treatment Induces CD4+ T Cell Exhaustion and Prolongs Survival in a Mouse Model of Systemic Lupus Erythematosus

被引:0
|
作者
Gonzalez, Nancy Mize [1 ,2 ]
Zou, Dawei [1 ]
Zeng, Zihua [3 ]
Feng, Frances Xiuyan [4 ]
Zhang, Xiaolong [1 ]
Sannes, Caitlin [1 ]
Gu, Andy [1 ]
Zu, Youli [3 ]
Chen, Wenhao [1 ,2 ,5 ]
机构
[1] Houston Methodist Hosp, Houston Methodist Res Inst, Immunobiol & Transplant Sci Ctr, Dept Surg, Houston, TX 77030 USA
[2] Texas A&M Univ, Coll Med, College Stn, TX 77840 USA
[3] Houston Methodist Hosp, Dept Pathol & Genom Med, Houston, TX USA
[4] Univ Colorado Anschutz Med Campus, Dept Pathol, Aurora, CO USA
[5] Cornell Univ, Dept Surg, Weill Cornell Med, New York, NY 14850 USA
关键词
CD4; cell; exhaustion; lupus/SLE; AUTOIMMUNITY; TH17;
D O I
10.1111/imm.13881
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
T cells play a critical role in the pathogenesis of systemic lupus erythematosus (SLE). Chronic T cell receptor (TCR) signalling induces T cell exhaustion, characterised by reduced capacity to induce tissue damage. Here, we investigated the therapeutic potential of the anti-TCR beta (H57-597) monoclonal antibody (mAb) in a mouse model of SLE. Four-month-old MRL/lpr mice exhibiting SLE phenotypes received 5 weekly doses of anti-TCR beta mAb or phosphate-buffered saline (PBS) vehicle control. Subsequently, mouse survival was monitored daily. On day 1 post the final dose of treatment, SLE pathogenesis was determined using histological staining and spot urine test. T and B cell states in the brain, kidney, and secondary lymphoid organs were determined by flow cytometry. Transient treatment of anti-TCR beta mAb significantly prolonged the survival of MRL/lpr mice. Accordingly, MRL/lpr mice in the anti-TCR beta mAb group exhibited decreased proteinuria scores and minimal renal pathological damage compared to the PBS control group. Flow cytometric analysis revealed that anti-TCR beta mAb treatment resulted in a reduction in the frequencies of CD4+ T cells and CD138+B220lo/- plasma cells, plus an increase in Foxp3+ regulatory T cell frequency. Furthermore, CD4+ T cells from anti-TCR beta mAb treated mice exhibited elevated expression levels of PD-1 and TIM-3, with reduced IFN-gamma production, indicative of an exhaustion-like phenotype. Therefore, transient administration of anti-TCR beta mAb treatment induces an exhaustion-like phenotype in CD4+ T cells, resulting in prolonged survival of MRL/lpr mice. Inducing autoreactive T-cell exhaustion holds promise as an attractive therapeutic approach for SLE.
引用
收藏
页码:239 / 246
页数:8
相关论文
共 50 条
  • [11] TIGIT signalling pathway negatively regulates CD4+ T-cell responses in systemic lupus erythematosus
    Mao, Lie
    Hou, Hongyan
    Wu, Shiji
    Zhou, Yu
    Wang, Juan
    Yu, Jing
    Wu, Xiaohui
    Lu, Yanfang
    Mao, Liyan
    Bosco, Munyemana Jean
    Wang, Feng
    Sun, Ziyong
    IMMUNOLOGY, 2017, 151 (03) : 280 - 290
  • [12] Effects of glucocorticoiids on expression of CD4+ Foxp3+ T cell in patients with systemic lupus erythematosus
    Zhao, Sheng -Nan
    Hou, Ya -Yi
    Sun, Ling-Yun
    PROGRESS ON POST-GENOME TECHNOLOGIES, 2007, : 315 - 317
  • [13] Enrichment of CD4+ CD25high T cell population in patients with systemic lupus erythematosus treated with glucocorticoids
    Suarez, A.
    Lopez, P.
    Gomez, J.
    Gutierrez, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 (11) : 1512 - 1517
  • [14] CD4+ CD52lo T-cell expression contributes to the development of Check for systemic lupus erythematosus
    Umeda, Masataka
    Koga, Tomohiro
    Ichinose, Kunihiro
    Igawa, Takashi
    Sato, Tomohito
    Takatani, Ayuko
    Shimizu, Toshimasa
    Fukui, Shoichi
    Nishino, Ayako
    Horai, Yoshiro
    Hirai, Yasuko
    Kawashiri, Shin-ya
    Iwamoto, Naoki
    Aramaki, Toshiyuki
    Tamai, Mami
    Nakamura, Hideki
    Yamamoto, Kazuo
    Abiru, Norio
    Origuchi, Tomoki
    Ueki, Yukitaka
    Kawakami, Atsushi
    CLINICAL IMMUNOLOGY, 2018, 187 : 50 - 57
  • [15] Therapeutic efficacy of anti-CD19 CAR-T cells in a mouse model of systemic lupus erythematosus
    Xuexiao Jin
    Qin Xu
    Chengfei Pu
    Kaixiang Zhu
    Cheng Lu
    Yu Jiang
    Lei Xiao
    Yongmei Han
    Linrong Lu
    Cellular & Molecular Immunology, 2021, 18 : 1896 - 1903
  • [16] Therapeutic efficacy of anti-CD19 CAR-T cells in a mouse model of systemic lupus erythematosus
    Jin, Xuexiao
    Xu, Qin
    Pu, Chengfei
    Zhu, Kaixiang
    Lu, Cheng
    Jiang, Yu
    Xiao, Lei
    Han, Yongmei
    Lu, Linrong
    CELLULAR & MOLECULAR IMMUNOLOGY, 2021, 18 (08) : 1896 - 1903
  • [17] Altered homeostasis of CD4+ FoxP3+ regulatory T-cell subpopulations in systemic lupus erythematosus
    Suen, Jau-Ling
    Li, Hsiao-Ting
    Jong, Yuh-Jyh
    Chiang, Bor-Luen
    Yen, Jeng-Hsien
    IMMUNOLOGY, 2009, 127 (02) : 196 - 205
  • [18] Low-dose interleukin-2 treatment selectively modulates CD4+ T cell subsets in patients with systemic lupus erythematosus
    Jing He
    Xia Zhang
    Yunbo Wei
    Xiaolin Sun
    Yaping Chen
    Jun Deng
    Yuebo Jin
    Yuzhou Gan
    Xin Hu
    Rulin Jia
    Chuanhui Xu
    Zhaohua Hou
    Yew Ann Leong
    Lei Zhu
    Jinhong Feng
    Yuan An
    Yuan Jia
    Chun Li
    Xu Liu
    Hua Ye
    Limin Ren
    Ru Li
    Haihong Yao
    Yuhui Li
    Shi Chen
    Xuewu Zhang
    Yin Su
    Jianping Guo
    Nan Shen
    Eric F Morand
    Di Yu
    Zhanguo Li
    Nature Medicine, 2016, 22 : 991 - 993
  • [19] Low-dose interleukin-2 treatment selectively modulates CD4+ T cell subsets in patients with systemic lupus erythematosus
    He, Jing
    Zhang, Xia
    Wei, Yunbo
    Sun, Xiaolin
    Chen, Yaping
    Deng, Jun
    Jin, Yuebo
    Gan, Yuzhou
    Hu, Xin
    Jia, Rulin
    Xu, Chuanhui
    Hou, Zhaohua
    Leong, Yew Ann
    Zhu, Lei
    Feng, Jinhong
    An, Yuan
    Jia, Yuan
    Li, Chun
    Liu, Xu
    Ye, Hua
    Ren, Limin
    Li, Ru
    Yao, Haihong
    Li, Yuhui
    Chen, Shi
    Zhang, Xuewu
    Su, Yin
    Guo, Jianping
    Shen, Nan
    Morand, Eric F.
    Yu, Di
    Li, Zhanguo
    NATURE MEDICINE, 2016, 22 (09) : 991 - +
  • [20] Enhanced proliferative response of CD4+ T cells from patients with systemic lupus erythematosus by T-cell receptor stimulation
    S Park
    I Kang
    H Kim
    J Craft
    Arthritis Res Ther, 5